We are live on ! Find out more
SS

SBI Securities Portfolio holdings

AUM $4.4B
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-0.93%
1 Year Est. Return
+74.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.65B
AUM Growth
-$241M
Cap. Flow
-$81.5M
Cap. Flow %
-2.23%
Top 10 Hldgs %
41.88%
Holding
4,187
New
171
Increased
1,575
Reduced
1,341
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 27.7%
2 Communication Services 6.87%
3 Consumer Discretionary 6.05%
4 Healthcare 3.13%
5 Financials 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIO icon
3001
Mustang Bio
MBIO
$4.78M
$371 ﹤0.01%
509
-1,500
-75% -$1.41K
NCSM icon
3002
NCS Multistage Holdings
NCSM
$117M
$371 ﹤0.01%
6
+1
+20% +$47
ACIW icon
3003
ACI Worldwide
ACIW
$6.1B
$369 ﹤0.01%
9
FLS icon
3004
Flowserve
FLS
$9.38B
$368 ﹤0.01%
5
GNE icon
3005
Genie Energy
GNE
$378M
$368 ﹤0.01%
26
-22
-46% -$312
CBLL
3006
CeriBell Inc
CBLL
$677M
$367 ﹤0.01%
20
DRUG
3007
Bright Minds Biosciences
DRUG
$706M
$365 ﹤0.01%
5
DMRA
3008
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.81B
$363 ﹤0.01%
14
LEA icon
3009
Lear
LEA
$7.45B
$363 ﹤0.01%
3
-2
-40% -$249
LILAK icon
3010
Liberty Latin America Class C
LILAK
$1.65B
$362 ﹤0.01%
45
+3
+7% +$21
WHG icon
3011
Westwood Holdings Group
WHG
$187M
$362 ﹤0.01%
22
+2
+10% +$34
QNTM
3012
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$19.2M
$362 ﹤0.01%
75
+20
+36% +$90
BELFA icon
3013
Bel Fuse Inc Class A
BELFA
$2.99B
$360 ﹤0.01%
+2
New +$383
URGN icon
3014
UroGen Pharma
URGN
$1.99B
$360 ﹤0.01%
20
+2
+11% +$40
PBYI icon
3015
Puma Biotechnology
PBYI
$406M
$358 ﹤0.01%
56
CNVS icon
3016
Cineverse
CNVS
$56.4M
$353 ﹤0.01%
147
+9
+7% +$22
MSGE icon
3017
Madison Square Garden
MSGE
$3.65B
$353 ﹤0.01%
6
+1
+20% +$59
SAIA icon
3018
Saia
SAIA
$10.9B
$351 ﹤0.01%
1
-1
-50% -$365
ASYS icon
3019
Amtech Systems
ASYS
$257M
$350 ﹤0.01%
30
-100
-77% -$1.35K
CINT icon
3020
CI&T Inc
CINT
$422M
$350 ﹤0.01%
69
-9
-12% -$44
IMNM icon
3021
Immunome
IMNM
$2.63B
$350 ﹤0.01%
16
+7
+78% +$156
EGBN icon
3022
Eagle Bancorp
EGBN
$866M
$348 ﹤0.01%
14
-3
-18% -$75
WSC icon
3023
WillScot Mobile Mini Holdings
WSC
$4.66B
$347 ﹤0.01%
20
ALLT icon
3024
Allot
ALLT
$373M
$346 ﹤0.01%
52
-2
-4% -$18
TRVI icon
3025
Trevi Therapeutics
TRVI
$2.62B
$346 ﹤0.01%
+29
New +$325

Similar funds

SBI Securities's Q1 2026 Portfolio in Review

As of Q1 2026, SBI Securities held 4,187 positions worth $3.65B, down 6.2% from $3.89B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

SBI Securities's Q1 2026 filing shows 171 new, 1,575 increased, 1,341 reduced and 158 closed positions. Its largest new stake was PayPay: 67,089 shares worth $1.43M. The largest sale was Berkshire Hathaway Class B, an estimated $37.3M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • SBI Securities's largest Q1 2026 buy was PayPay: 67,089 shares worth $1.43M.
  • SBI Securities added most to Atlassian in Q1 2026, an estimated $14.9M increase.
  • SBI Securities's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $20.5M.
  • SBI Securities fully exited Berkshire Hathaway Class B in Q1 2026, selling an estimated $37.3M.
  • SBI Securities's ten largest holdings make up 42% of its $3.65B portfolio in Q1 2026.
  • SBI Securities opened 171 new positions and closed 158 in Q1 2026.
  • SBI Securities's portfolio value fell 6.2% quarter-over-quarter to $3.65B.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.